SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Ardelyx, Inc. (ARDX)

ARDX RSS Feed
Add ARDX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/19/2016 4:48:54 PM - Followers: 0 - Board type: Free - Posts Today: 0

Ardelyx, Inc. 34175 Ardenwood Boulevard Suite 100 Fremont, CA 94555 United States Phone: 510-745-1700 Fax: 510-745-0493 Website: http://www.ardelyx.com Ardelyx, Inc. discovers, develops, and commercializes minimally-systemic small molecule therapeutics for the gastrointestinal (GI) tract to treat cardio-renal, GI, and metabolic diseases. Its lead product candidate is tenapanor, a small molecule NHE3 inhibitor, which has completed Phase 2b clinical trial for the treatment of patients with constipation-predominant irritable bowel syndrome and hyperphosphatemic patients with chronic kidney disease on dialysis, as well as Phase 2a clinical trial in patiets with late-stage chronic kidney disease. The company’s discovery and lead development programs that are in research phase include RDX002 NaP2b inhibitor for hyperphosphatemia; RDX009 TGR5 agonists for inflammatory bowel disease, short bowel syndrome, and non-alcoholic steatohepatitis; and RDX013 for hyperkalemia. It has a collaboration partnership agreement with AstraZeneca AB for the development and commercialization of tenapanor. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARDX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ARDX News: Additional Proxy Soliciting Materials (definitive) (defa14a) 04/25/2017 05:19:18 PM
ARDX News: Proxy Statement (definitive) (def 14a) 04/25/2017 05:17:34 PM
ARDX News: Securities Registration Statement (simplified Form) (s-3) 04/24/2017 05:30:02 PM
ARDX News: Statement of Changes in Beneficial Ownership (4) 04/21/2017 06:58:35 PM
ARDX News: Ardelyx To Present at Upcoming Spring Medical Meetings 04/18/2017 06:30:00 AM
PostSubject
#4   ARDX bullish 9.19 stocktrademan 08/19/16 04:48:54 PM
#3   ARDX bullish 10.375 stocktrademan 08/16/16 10:24:42 AM
#2   ARDX bullish 11.00 stocktrademan 07/21/16 01:09:59 PM
#1   $ARDX recent news/filings stocktrademan 11/25/15 02:11:45 PM
PostSubject